Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Equity Average: 2016-2025

Historic Equity Average for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $253.5 million.

  • Collegium Pharmaceutical's Equity Average rose 12.45% to $253.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $253.5 million, marking a year-over-year increase of 12.45%. This contributed to the annual value of $212.1 million for FY2024, which is 8.71% up from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Equity Average is $253.5 million, which was up 8.65% from $233.3 million recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Equity Average high stood at $253.5 million for Q3 2025, and its period low was $178.0 million during Q1 2021.
  • In the last 3 years, Collegium Pharmaceutical's Equity Average had a median value of $219.4 million in 2024 and averaged $214.4 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Equity Average skyrocketed by 55.83% in 2021 and then fell by 21.69% in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's Equity Average (Quarterly) stood at $227.0 million in 2021, then fell by 13.65% to $196.0 million in 2022, then fell by 4.52% to $187.2 million in 2023, then climbed by 23.73% to $231.6 million in 2024, then rose by 12.45% to $253.5 million in 2025.
  • Its Equity Average was $253.5 million in Q3 2025, compared to $233.3 million in Q2 2025 and $231.6 million in Q1 2025.